Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Phathom Pharmaceuticals (PHAT) Return on Capital Employed (2022 - 2025)

Historic Return on Capital Employed for Phathom Pharmaceuticals (PHAT) over the last 4 years, with Q3 2025 value amounting to 1.4%.

  • Phathom Pharmaceuticals' Return on Capital Employed fell 4000.0% to 1.4% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.4%, marking a year-over-year decrease of 4000.0%. This contributed to the annual value of 0.89% for FY2024, which is 2300.0% down from last year.
  • According to the latest figures from Q3 2025, Phathom Pharmaceuticals' Return on Capital Employed is 1.4%, which was down 4000.0% from 1.49% recorded in Q2 2025.
  • Phathom Pharmaceuticals' 5-year Return on Capital Employed high stood at 0.58% for Q4 2023, and its period low was 1.49% during Q2 2025.
  • Moreover, its 4-year median value for Return on Capital Employed was 0.97% (2024), whereas its average is 0.98%.
  • Per our database at Business Quant, Phathom Pharmaceuticals' Return on Capital Employed skyrocketed by 5700bps in 2024 and then plummeted by -6200bps in 2025.
  • Quarter analysis of 4 years shows Phathom Pharmaceuticals' Return on Capital Employed stood at 1.1% in 2022, then soared by 47bps to 0.58% in 2023, then plummeted by -60bps to 0.93% in 2024, then plummeted by -50bps to 1.4% in 2025.
  • Its Return on Capital Employed was 1.4% in Q3 2025, compared to 1.49% in Q2 2025 and 1.09% in Q1 2025.